SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-20-126361
Filing Date
2020-04-29
Accepted
2020-04-29 16:45:59
Documents
3
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d923343d10ka.htm 10-K/A 284149
2 EX-31.3 d923343dex313.htm EX-31.3 3205
3 EX-31.4 d923343dex314.htm EX-31.4 3191
  Complete submission text file 0001193125-20-126361.txt   291816
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33057 | Film No.: 20831069
SIC: 2834 Pharmaceutical Preparations